Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2010-022660-12Phase 3Terminated
Phase 3, randomised, double-blind trial in liver transplant comparing Iloprost with Placebo (2 arms). Primary endpoint: Primary graft dysfunction after liver transplantation. Started Nov 2010; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2010-022660-12.